FORM 3
        
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

OMB APPROVAL
OMB Number: 3235-0104
Estimated average burden
hours per response... 0.5
                      
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
                      

1. Name and Address of Reporting Person *

Elliott Mark Stuart

2. Date of Event Requiring Statement (MM/DD/YYYY)
7/31/2015 

3. Issuer Name and Ticker or Trading Symbol

PURE BIOSCIENCE, INC. [PURE]

(Last)        (First)        (Middle)

1725 GILLESPIE WAY

4. Relationship of Reporting Person(s) to Issuer (Check all applicable)

_____ Director                            _____ 10% Owner
___ X ___ Officer (give title below)          _____ Other (specify below)
Vice President, Finance /

(Street)

EL CAJON, CA 92020       

(City)              (State)              (Zip)
5. If Amendment, Date Original Filed (MM/DD/YYYY)

 

6. Individual or Joint/Group Filing (Check Applicable Line)

_ X _ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person


Table I - Non-Derivative Securities Beneficially Owned
1.Title of Security
(Instr. 4) 		2. Amount of Securities Beneficially Owned
(Instr. 4) 		3. Ownership Form: Direct (D) or Indirect (I)
(Instr. 5) 		4. Nature of Indirect Beneficial Ownership
(Instr. 5)
Common Stock   11550   D    

Table II - Derivative Securities Beneficially Owned ( e.g. , puts, calls, warrants, options, convertible securities)
1. Title of Derivate Security
(Instr. 4) 		2. Date Exercisable and Expiration Date
(MM/DD/YYYY) 		3. Title and Amount of Securities Underlying Derivative Security
(Instr. 4) 		4. Conversion or Exercise Price of Derivative Security 5. Ownership Form of Derivative Security: Direct (D) or Indirect (I)
(Instr. 5) 		6. Nature of Indirect Beneficial Ownership
(Instr. 5)
Date Exercisable Expiration Date Title Amount or Number of Shares
Stock Options (Right to Buy)   5/14/2009   5/14/2019   Common Stock   2500   $18.72   D    
Stock Options (Right to Buy)   5/19/2010   5/19/2020   Common Stock   2500   $28.00   D    
Stock Options (Right to Buy)   1/14/2011   7/14/2021   Common Stock   6875   $6.72   D    
Stock Options (Right to Buy)   1/24/2013   1/24/2023   Common Stock   10000   $0.86   D    
Stock Options (Right to Buy)     (1) 12/16/2016   Common Stock   100000   $1.40   D    

Explanation of Responses:
( 1)  50% of the option shares were fully vested as of June 16, 2015 and the remaining shares vest in 6 equal quarterly installments begining on September 16, 2015.

Reporting Owners
Reporting Owner Name / Address
Relationships
Director 10% Owner Officer Other
Elliott Mark Stuart
1725 GILLESPIE WAY
EL CAJON, CA 92020

Vice President, Finance

Signatures
/s/ Mark Stuart Elliott 7/31/2015
** Signature of Reporting Person Date


Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5(b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.
PURE Bioscience (PK) (USOTC:PURE)
Historical Stock Chart
From Jun 2024 to Jul 2024 Click Here for more PURE Bioscience (PK) Charts.
PURE Bioscience (PK) (USOTC:PURE)
Historical Stock Chart
From Jul 2023 to Jul 2024 Click Here for more PURE Bioscience (PK) Charts.